12:00 AM
Jun 26, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ampligen nucleic acid antiviral agent regulatory update

HEB's Hemispherx Biopharma Europe NV/SA subsidiary (Antwerp, Belgium) submitted for comment a draft version of its European application...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >